Sökning: L773:1527 9995 OR L773:0090 4295
> (2020-2024) >
Surveillance for No...
Surveillance for Nonmuscle Invasive Bladder Cancer: Identifying the Point of Diminishing Returns
-
Ranti, Daniel (författare)
-
Dey, Linda (författare)
-
Bieber, Christine (författare)
-
visa fler...
-
Grauer, Ralph (författare)
-
Rich, Jordan (författare)
-
Rosenzweig, Shoshana (författare)
-
- Koskela, Lotta Renstroem (författare)
- Karolinska Institutet
-
- Steineck, Gunnar, 1952 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology
-
Hosseini, Abolfazl (författare)
-
- Egevad, Lars (författare)
- Karolinska Institutet
-
Patrakka, Jaakko (författare)
-
Attalla, Kyrollis (författare)
-
- Wiklund, Peter (författare)
- Karolinska Institutet
-
Sfakianos, John (författare)
-
Waingankar, Nikhil (författare)
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska.
-
Ingår i: UROLOGY. - 0090-4295 .- 1527-9995. ; 181, s. 84-91
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- OBJECTIVE To characterize first and second recurrence patterns using 26 years of cohort-level follow-up and microsimulation modeling.METHODS Patients diagnosed with nonmuscle-invasive bladder cancer in Stockholm County between 1995 and 1996 were included. Clinical, pathological, and longitudinal follow-up data were gathered. Logistic regressions, Kaplan Meier curves, and Cox proportional hazards models were run to generate assumptions for a microsimulation model, simulating first and second recurrence and progression for 10,000 patients.RESULTS Three hundred eighty-six patients were included: 67.4% were male; > 50% were TaLG; and 37.5% were American Urological Association high-risk. Median time to recurrence was 300 days. Three patients had missing data. Cohort follow-up has been carried out for 26 years. For simulated firstrecurrences, low-risk patients recurred at 56.6% over 15 years of follow-up, with 2.2% muscleinvasive (MI) progression; intermediate-risk patients recurred at 62.8%, with 4.3% MI progression; high-risk patients recurred at 48.7% over 15 years, with MI progression at 14.3%. For second recurrences, 70.7%, 75.7%, and 84.7% of low, medium, and high-risk patients recurred. No patients were seen to have first recurrences after 9 years, with low, but notable, rates beyond 5 years.CONCLUSION These data suggest that low-, intermediate-, and high-risk patients without recurrence at 5 years may be potentially transitioned to less invasive monitoring.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
UROLOGY
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Ranti, Daniel
-
Dey, Linda
-
Bieber, Christin ...
-
Grauer, Ralph
-
Rich, Jordan
-
Rosenzweig, Shos ...
-
visa fler...
-
Koskela, Lotta R ...
-
Steineck, Gunnar ...
-
Hosseini, Abolfa ...
-
Egevad, Lars
-
Patrakka, Jaakko
-
Attalla, Kyrolli ...
-
Wiklund, Peter
-
Sfakianos, John
-
Waingankar, Nikh ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
UROLOGY
- Av lärosätet
-
Göteborgs universitet
-
Karolinska Institutet